Omeros Corp. (3O8)
FSX
Delayed Data
Oct 19, 2026, 06:00 AM
Day's Range
14.1552 wk Range
5.37Overview - 3O8 - Omeros Corp.
Key Statistics
Valuation
Enterprise Value
1.27B
P/E (Trailing)
‪15.97‬
P/E (Forward)
‪-13.26‬
PEG Ratio
‪-0.11‬
Price / Sales (TTM)
‪32.49‬
Price / Book
‪-24.23‬
EV / EBITDA
‪-19.75‬
Profitability
Gross Margin
‪97.20%‬
Profit Margin
‪324.88%‬
Operating Margin
‪0.25%‬
Return on Assets
‪-18.67%‬
Return on Equity
‪2.76%‬
Ownership
Shares Outstanding
72.08M
Float
69.28M
Held by Insiders
‪4.08%‬
Held by Institutions
‪51.43%‬
Price stats
Beta
‪2.57‬
50-Day Avg
‪15.32‬
200-Day Avg
‪11.19‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 3O8 - Omeros Corp.
Peers - 3O8 - Omeros Corp.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- 3O8FSXOmeros Corp.1.24BMarket Cap+48.78%52-week change15.97P/E (Trailing)‪324.88%‬Profit Margin
- ANLFSXAnalog Devices Inc.173.23BMarket Cap+42.13%52-week change49.48P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.75.83BMarket Cap+88.13%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 1AEFSXargenx SE46.38BMarket Cap+7.13%52-week change36.55P/E (Trailing)‪32.26%‬Profit Margin
- 64BFSXAstera Labs, Inc.45.97BMarket Cap+48.68%52-week change176.19P/E (Trailing)‪30.74%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt45.90BMarket Cap-5.00%52-week change32.46P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.36.20BMarket Cap+75.13%52-week change-28.39P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - 3O8 - Omeros Corp.
About
Omeros Corp. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics. The company concentrates on immunologic and complement-mediated diseases, along with selected orphan and rare indications affecting inflammation, coagulopathies,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
